Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach. The esomeprazole capsules are also approved to reduce the risk of gastric ulcers associated with use of non-steroidal anti-inflammatory drugs.
Ivax Pharmaceuticals, a subsidiary of Teva Pharmaceuticals USA, developed the capsules.
More articles on GI/endoscopy:
14 statistics on gastroenterologist burnout
GI physician leader to know: Dr. Peter Banks of Brigham and Women’s Hospital
Actavis to acquire Auden Mckenzie for approximately $460M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
